Publications


  1. Ultra-high dose-rate irradiation experiments at FLUTE
    Nasse, M.; Brosi, M.; Pehlivan, J.; Goldbach, S.; Treffert, S. M.; Malygin, A.; Bründermann, E.; Orian-Rousseau, V.; Müller, A. S.
    2026, May 19. 17th International Particle Accelerator Conference (IPAC 2026), Deauville, France, May 17–22, 2026 
  2. Regulation and Function of Sox2 and CD Expression in the Stomach by Bone Morphogenetic Protein Signaling
    Todisco, A.; Colacino, J.; Lesniak, N.; Peng, L.; Li, X.; Takeda, T.; Wei, X.; Mao, M.; Orian-Rousseau, V.; Eaton, K. A.
    2026. Gastro Hep Advances, 5 (12), Art.Nr: 101075. doi:10.1016/j.gastha.2026.101075 Full textFull text of the publication as PDF document 
  3. Ultra-high dose-rate irradiation experiments at FLUTE
    Nasse, M. J.; Müller, A.-S.; Brosi, M.; Malygin, A.; Bründermann, E.; Goldbach, D.; Orian-Rousseau, V.; Pehlivan, J.; Treffert, S. M.
    2026. 17th International Particle Accelerator Conference (IPAC 2026), TUP8008, JACoW Publishing 
  4. Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions
    Treffert, S. M.; Heneka, Y. M.; Martin, J.; Gargano, A.; Launhardt, L.; Akilli, Ö.; Stanganello, E.; Andrieux, G.; Hoch, D.; Sonnentag, S. J.; Mehner, L.-M.; Munoz-Sagredo, L.; Christ, M.; Orian-Rousseau, V.
    2026. Cell Death & Disease, 17 (1), 729. doi:10.1038/s41419-026-09155-5 Full textFull text of the publication as PDF document 
  5. CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis
    Bourinet, M.; Vieira, E.; Rousseau, D.; Bonnafous, S.; Soysouvanh, F.; Strazzulla, A.; Elliot, C.; Patouraux, S.; Leclère, P. S.; Moskalevska, I.; Cherfils-Vicini, J.; Tulic, M. K.; Mack, M.; Bailly-Maitre, B.; Orian-Rousseau, V.; Iannelli, A.; Belmer, A.; Tran, A.; Anty, R.; Gual, P.; Luci, C.
    2025. Liver International, 45 (9), e70299. doi:10.1111/liv.70299 Full textFull text of the publication as PDF document 
  6. CD44 in myEloid cells is a major driver of liver inflammation and injury in alcohol-related liver disease
    Rousseau, D.; Bonnafous, S.; Soysouvanh, F.; Sarrail, D.; Bourinet, M.; Strazzulla, A.; Patouraux, S.; Borderie, A.; Dolfi, B.; Gallerand, A.; Farrugia, M. A.; Orian-rousseau, V.; Xu, Y.; Williams, J. W.; Ivanov, S.; Tran, A.; Anty, R.; Luci, C.; Gual, P.
    2025. Hepatology. doi:10.1097/HEP.0000000000001232 Full textFull text of the publication as PDF document 
  7. CD44: a stemness driver, regulator, and marker—all in one?
    Sonnentag, S. J.; Ibrahim, N. S. M.; Orian-Rousseau, V.
    2024. Stem Cells, 42 (12), 1031–1039. doi:10.1093/stmcls/sxae060 
  8. High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfaces
    Sonnentag, S. J.; Jenne, F.; Orian-Rousseau, V.; Nesterov-Mueller, A.
    2024. Communications Biology, 7 (1), Art.-Nr.: 870. doi:10.1038/s42003-024-06541-7 Full textFull text of the publication as PDF document 
  9. Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis
    Mehner, L.-M.; Munoz-Sagredo, L.; Sonnentag, S. J.; Treffert, S. M.; Orian-Rousseau, V.
    2024. Clinical and Experimental Metastasis. doi:10.1007/s10585-024-10292-4 Full textFull text of the publication as PDF document 
  10. Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B
    Tannoo, R. M.; Richert, L.; Koschut, D.; Tomishige, N.; Treffert, S. M.; Kobayashi, T.; Mély, Y.; Orian-Rousseau, V.
    2024. Biochimica et Biophysica Acta (BBA) - Biomembranes, 1866 (1), Art.-Nr. 184236. doi:10.1016/j.bbamem.2023.184236 Full textFull text of the publication as PDF document 
  11. Identification of an imidazopyridine-based compound as an oral selective estrogen receptor degrader for breast cancer therapy
    Pan, M.; Solozobova, V.; Kuznik, N. C.; Jung, N.; Graessle, S.; Gourain, V.; Heneka, Y. M.; Cramer von Clausbruch, C. A.; Fuhr, O.; Munuganti, R. S. N.; Maddalo, D.; Blattner, C.; Neeb, A.; Sharp, A.; Cato, L.; Weiss, C.; Jeselsohn, R. M.; Orian-Rousseau, V.; Bräse, S.; Cato, A. C. B.
    2023. Cancer Research Communications, 3 (7), 1378–1396. doi:10.1158/2767-9764.CRC-23-0111 Full textFull text of the publication as PDF document 
  12. Automated high-throughput image processing as part of the screening platform for personalized oncology
    Schilling, M. P.; El Khaled El Faraj, R.; Urrutia Gómez, J. E.; Sonnentag, S. J.; Wang, F.; Nestler, B.; Orian-Rousseau, V.; Popova, A. A.; Levkin, P. A.; Reischl, M.
    2023. Scientific Reports, 13, Article no: 5107. doi:10.1038/s41598-023-32144-z Full textFull text of the publication as PDF document 
  13. Direct interaction of TrkA/CD44v3 is essential for NGF-promoted aggressiveness of breast cancer cells
    Trouvilliez, S.; Cicero, J.; Lévêque, R.; Aubert, L.; Corbet, C.; Van Outryve, A.; Streule, K.; Angrand, P.-O.; Völkel, P.; Magnez, R.; Brysbaert, G.; Mysiorek, C.; Gosselet, F.; Bourette, R.; Adriaenssens, E.; Thuru, X.; Lagadec, C.; de Ruyck, J.; Orian-Rousseau, V.; Le Bourhis, X.; Toillon, R.-A.
    2022. Journal of Experimental & Clinical Cancer Research, 41 (1), Art.-Nr. 110. doi:10.1186/s13046-022-02314-4 Full textFull text of the publication as PDF document 
  14. Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behaviour in colon cancer
    Xu, T.; Verhagen, M.; Joosten, R.; Sun, W.; Sacchetti, A.; Munoz Sagredo, L.; Orian-Rousseau, V.; Fodde, R.
    2022. eLife, 11, Art.-Nr.: e82006. doi:10.7554/eLife.82006 Full textFull text of the publication as PDF document 
  15. Different Involvement of Vimentin during Invasion by Listeria monocytogenes at the Blood–Brain and the Blood–Cerebrospinal Fluid Barriers In Vitro
    Banovic, F.; Schulze, S.; Abu Mraheil, M.; Hain, T.; Chakraborty, T.; Orian-Rousseau, V.; Moroniak, S.; Weiss, C.; Ishikawa, H.; Schroten, H.; Adam, R.; Schwerk, C.
    2022. International Journal of Molecular Sciences, 23 (21), Art.Nr. 12908. doi:10.3390/ijms232112908 Full textFull text of the publication as PDF document 
  16. CD44 expressed by myeloid cells promotes glioma invasion
    Ivanova, E. L.; Costa, B.; Eisemann, T.; Lohr, S.; Boskovic, P.; Eichwald, V.; Meckler, J.; Jugold, M.; Orian-Rousseau, V.; Peterziel, H.; Angel, P.
    2022. Frontiers in Oncology, 12, Art.Nr. 969787. doi:10.3389/fonc.2022.969787 
  17. Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop
    Walter, R. J.; Sonnentag, S. J.; Munoz-Sagredo, L.; Merkel, M.; Richert, L.; Bunert, F.; Heneka, Y. M.; Loustau, T.; Hodder, M.; Ridgway, R. A.; Sansom, O. J.; Mely, Y.; Rothbauer, U.; Schmitt, M.; Orian-Rousseau, V.
    2022. Cell death & disease, 13 (2), Art.-Nr.: 168. doi:10.1038/s41419-022-04607-0 Full textFull text of the publication as PDF document 
  18. A Guide to the Composition and Functions of the Extracellular Matrix
    Karamanos, N. K.; Theocharis, A. D.; Piperigkou, Z.; Manou, D.; Passi, A.; Skandalis, S. S.; Vynios, D. H.; Orian-Rousseau, V.; Ricard-Blum, S.; Schmelzer, C. E. H.; Duca, L.; Durbee, M.; Afratis, N. A.; Troeberg, L.; Franchi, M.; Masola, V.; Onisto, M.
    2021. The FEBS journal, 288 (24), 6850–6912. doi:10.1111/febs.15776 
  19. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues
    Yu, X.; Munoz-Sagredo, L.; Streule, K.; Muschong, P.; Bayer, E.; Walter, R. J.; Gutjahr, J. C.; Greil, R.; Concha, M. L.; Müller-Tidow, C.; Hartmann, T. N.; Orian-Rousseau, V.
    2021. Blood, 138 (12), 1067–1080. doi:10.1182/blood.2020006343 
  20. Plasticity in Colorectal Cancer: Why Cancer Cells Differentiate
    Walter, R. J.; Sonnentag, S. J.; Orian-Rousseau, V.; Munoz-Sagredo, L.
    2021. Cancers, 13 (4), Art.Nr. 918. doi:10.3390/cancers13040918 Full textFull text of the publication as PDF document 
  21. BeadNet: Deep learning-based bead detection and counting in low-resolution microscopy images
    Scherr, T.; Streule, K.; Bartschat, A.; Böhland, M.; Stegmaier, J.; Reischl, M.; Orian-Rousseau, V.; Mikut, R.
    2020. Bioinformatics, 36 (17), 4668–4670. doi:10.1093/bioinformatics/btaa594 Full textFull text of the publication as PDF document 
  22. Combinatorial Synthesis of a Lipidoid Library by Thiolactone Chemistry: In Vitro Screening and In Vivo Validation for siRNA Delivery
    Molla, M. R.; Chakraborty, S.; Munoz-Sagredo, L.; Drechsler, M.; Orian-Rousseau, V.; Levkin, P. A.
    2020. Bioconjugate chemistry, 31 (3), 852–860. doi:10.1021/acs.bioconjchem.0c00013 
  23. CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity
    Gutjahr, J. C.; Bayer, E.; Yu, X.; Laufer, J. M.; Höpner, J. P.; Tesanovic, S.; Härzschel, A.; Auer, G.; Rieß, T.; Salmhofer, A.; Szenes, E.; Haslauer, T.; Durand-Onayli, V.; Ramspacher, A.; Pennisi, S. P.; Artinger, M.; Zaborsky, N.; Chigaev, A.; Aberger, F.; Neureiter, D.; Pleyer, L.; Legler, D. F.; Orian-Rousseau, V.; Greil, R.; Hartmann, T. N.
    2020. Haematologica, 106 (8), 2102–2113. doi:10.3324/haematol.2019.231944 Full textFull text of the publication as PDF document 
  24. Breast Cancer-Derived Microparticles Reduce Cancer Cell Adhesion, an Effect Augmented by Chemotherapy
    Shechter, D.; Harel, M.; Mukherjee, A.; Sagredo, L. M.; Loven, D.; Prinz, E.; Avraham, S.; Orian-Rousseau, V.; Geiger, T.; Shaked, Y.; Wolfenson, H.
    2020. Cells, 9 (10), 2269. doi:10.3390/cells9102269 Full textFull text of the publication as PDF document 
  25. Regulation of Staphylococcus aureus Infection of Macrophages by CD44, Reactive Oxygen Species, and Acid Sphingomyelinase
    Li, C.; Wu, Y.; Riehle, A.; Orian-Rousseau, V.; Zhang, Y.; Gulbins, E.; Grassmé, H.
    2018. Antioxidants & redox signaling, 28 (10), 916–934. doi:10.1089/ars.2017.6994 
  26. TGFβ counteracts LYVE-1-mediated induction of lymphangiogenesis by small hyaluronan oligosaccharides
    Bauer, J.; Rothley, M.; Schmaus, A.; Quagliata, L.; Ehret, M.; Biskup, M.; Orian-Rousseau, V.; Jackson, D. G.; Pettis, R. J.; Harvey, A.; Bräse, S.; Thiele, W.; Sleeman, J. P.
    2018. Journal of molecular medicine, 96 (2), 199–209. doi:10.1007/s00109-017-1615-4 
  27. Differential recruitment of CD44 isoforms by ErbB ligands reveals an involvement of CD44 in breast cancer
    Morath, I.; Jung, C.; Lévêque, R.; Linfeng, C.; Toillon, R.-A.; Warth, A.; Orian-Rousseau, V.
    2018. Oncogene, 37, 1472–1484. doi:10.1038/s41388-017-0030-1 
  28. Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemia
    Gutjahr, J. C.; Szenes, E.; Tschech, L.; Asslaber, D.; Schlederer, M.; Roos, S.; Yu, X.; Girbl, T.; Sternberg, C.; Egle, A.; Aberger, F.; Alon, R.; Kenner, L.; Greil, R.; Orian-Rousseau, V.; Hartmann, T. N.
    2018. Blood, 131 (12), 1337–1349. doi:10.1182/blood-2017-08-802462 
  29. Functional Genomic mRNA Profiling of Colorectal Adenomas : Identification and Validation of CD44 and Splice Variant CD44v6 as Molecular Imaging Targets
    Hartmans, E.; Orian-Rousseau, V.; Matzke-Ogi, A.; Karrenbeld, A.; Groot, D. J. A. de; Jong, S. de; Dam, G. M. van; Fehrmann, R. S. N.; Nagengast, W. B.
    2017. Theranostics, 7 (2), 482–492. doi:10.7150/thno.16816 Full textFull text of the publication as PDF document 
  30. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer
    Preca, B.-T.; Bajdak, K.; Mock, K.; Lehmann, W.; Sundararajan, V.; Bronsert, P.; Matzge-Ogi, A.; Orian-Rousseau, V.; Brabletz, S.; Brabletz, T.; Maurer, J.; Stemmler, M. P.
    2017. OncoTarget, 8 (7), 11530–11543. doi:10.18632/oncotarget.14563 Full textFull text of the publication as PDF document 
  31. CD44v6-Peptide Functionalized Nanoparticles Selectively Bind to Metastatic Cancer Cells
    Li, L.; Schmitt, M.; Matzke-Ogi, A.; Wadhwani, P.; Orian-Rousseau, V.; Levkin, P. A.
    2017. Advanced science, 4 (1), Art.Nr. 1600202. doi:10.1002/advs.201600202 Full textFull text of the publication as PDF document 
  32. Hoffnung auf Heilung in 10 Jahren - neue Therapiemöglichkeit für Bauchspeichelkrebs am Karlsruher Institut für Technologie erprobt - Campusreport am 12.01.2016
    Fuchs, S.; Orian-Rousseau, V.
    2016. doi:10.5445/DIVA/2016-27 
  33. CD44 mediates the catch-bond activated rolling of HEPG2Iso epithelial cancer cells on hyaluronan
    Hanke-Roos, M.; Fuchs, K.; Maleschlijski, S.; Sleeman, J.; Orian-Rousseau, V.; Rosenhahn, A.
    2016. Cell adhesion & migration, 11 (5-6), 476–487. doi:10.1080/19336918.2016.1260809 
  34. CD44: More than a mere stem cell marker
    Morath, I.; Hartmann, T. N.; Orian-Rousseau, V.
    2016. International journal of biochemistry & cell biology, 81, 166–173. doi:10.1016/j.biocel.2016.09.009 
  35. Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress
    Shatirishvili, M.; Burk, A. S.; Franz, C. M.; Pace, G.; Kastilan, T.; Breuhahn, K.; Hinterseer, E.; Dierich, A.; Bakiri, L.; Wagner, E. F.; Ponta, H.; Hartmann, T. N.; Tanaka, M.; Orian-Rousseau, V.
    2016. Cell death & disease, 7, Article no: e2461. doi:10.1038/cddis.2016.342 Full textFull text of the publication as PDF document 
  36. Live cell imaging shows hepatocyte growth factor-induced Met dimerization
    Koschut, D.; Richert, L.; Pace, G.; Niemann, H. H.; Mely, Y.; Orian-Rousseau, V.
    2016. Biochimica et Biophysica Acta - Molecular Cell Research, 1863 (7), 1552–1558. doi:10.1016/j.bbamcr.2016.04.015 
  37. Fighting pancreatic cancer
    Orian-Rousseau, V.
    2016. Pan European Networks: Science and Technology, 18, 192–193 
  38. Inhibition of Tumor Growth and Metastasis in Pancreatic Cancer Models by Interference with CD44v6 Signaling
    Matzke-Ogi, A.; Jannasch, K.; Shatirishvili, M.; Fuchs, B.; Chiblak, S.; Morton, J.; Tawk, B.; Lindner, T.; Sansom, O.; Alves, F.; Warth, A.; Schwager, C.; Mier, W.; Kleeff, J.; Ponta, H.; Abdollahi, A.; Orian-Rousseau, V.
    2016. Gastroenterology, 150 (2), 513–525e10. doi:10.1053/j.gastro.2015.10.020 
  39. Metastasenbildung unterbinden - KIT Forscher entwickeln Therapie gegen Bauchspeicheldrüsenkrebs - Beitrag bei Radio KIT am 17.12.2015
    Warzecha, J.; Orian-Rousseau, V.
    2015. doi:10.5445/DIVA/2015-995 
  40. CD44 regulates Wnt signaling at the level of LRP6
    Orian-Rousseau, V.; Schmitt, M.
    2015. Molecular & cellular oncology, 2 (3), e995046. doi:10.4161/23723556.2014.995046 Full textFull text of the publication as PDF document 
  41. Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6
    Volz, Y.; Koschut, D.; Matzke-Ogi, A.; Dietz, M. S.; Karathanasis, C.; Richert, L.; Wagner, M. G.; Mély, Y.; Heilemann, M.; Niemann, H. H.; Orian-Rousseau, V.
    2015. Bioscience reports, 35 (4), e00236. doi:10.1042/BSR20150093 Full textFull text of the publication as PDF document 
  42. Role of CD44 in tumor progression and metastasis
    Matzke, A.; Sharirishvili, M.; Morath, I.; Orian-Rousseau, V.
    2015. 15th International Biennial Congress of the Metastasis Research Society, Heidelberg, June 28 - July 1, 2014 Clinical and Experimental Metastasis, 32(2015) (Abstract) 
  43. CD44 Plays a Functional Role in Helicobacter pylori-induced Epithelial Cell Proliferation
    Bertaux-Skeirik, N.; Feng, R.; Schumacher, M. A.; Li, J.; Mahe, M. M.; Engevik, A. C.; Javier, J. E.; Peek, R. M.; Ottemann, K.; Orian-Rousseau, V.; Boivin, G. P.; Helmrath, M. A.; Zavros, Y.
    2015. PLoS pathogens, 11 (2), 1–24/e1004663. doi:10.1371/journal.ppat.1004663 Full textFull text of the publication as PDF document 
  44. Paracrine met signaling triggers epithelial mesenchymal transition in mammary luminal progenitors, affecting their fate
    Di-Cicco, A.; Petit, V.; Chiche, A.; Bresson, L.; Romagnoli, M.; Orian-Rousseau, V.; Vivanco, M.; Medina, D.; Faraldo, M. M.; Glukhova, M. A.; Deugnier, M. A.
    2015. eLife, 4, e06104/1–25. doi:10.7554/eLife.06104 Full textFull text of the publication as PDF document 
  45. Perspectives of CD44 targeting therapies
    Orian-Rousseau, V.; Ponta, H.
    2015. Archives of toxicology, 89 (1), 3–14. doi:10.1007/s00204-014-1424-2 
  46. CD44 acts as a signaling platform controlling tumor progression and metastasis
    Orian-Rousseau, V.
    2015. Frontiers in immunology, 6 (154), 1–4. doi:10.3389/fimmu.2015.00154 Full textFull text of the publication as PDF document 
  47. CD44 functions in Wnt signaling by regulating LRP6 localization and activation
    Schmitt, M.; Metzger, M.; Gradl, D.; Davidson, G.; Orian-Rousseau, V.
    2015. Cell death and differentiation, 22, 677–689. doi:10.1038/cdd.2014.156 
  48. CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals
    Orian-Rousseau, V.; Sleeman, J.
    2014. Advances in cancer research, 123, 231–254. doi:10.1016/B978-0-12-800092-2.00009-5 
  49. Endocytosis of Fgf8 is a double-stage process and regulates spreading and signaling
    Rengarajan, C.; Matzke, A.; Reiner, L.; Orian-Rousseau, V.; Scholpp, S.
    2014. PLOS ONE, 9 (1), e86373/1–11. doi:10.1371/journal.pone.0086373 Full textFull text of the publication as PDF document 
  50. Internalization of Met requires the co-receptor CD44v6 and its link to ERM proteins
    Hasenauer, S.; Malinger, D.; Koschut, D.; Pace, G.; Matzke, A.; Au, A. von; Orian-Rousseau, V.
    2013. PLoS one, 8 (4), e62357/1–15. doi:10.1371/journal.pone.0062357 Full textFull text of the publication as PDF document 
  51. Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44
    Fuchs, K.; Hippe, A.; Schmaus, A.; Homey, B.; Sleeman, J. P.; Orian-Rousseau, V.
    2013. Cell death & disease, 4, Art. Nr. e819. doi:10.1038/cddis.2013.364 Full textFull text of the publication as PDF document 
  52. The surface proteins InlA and InlB are interdependently required for polar basolateral invasion by Listeria monocytogenes in a human model of the blood-cerebrospinal fluid barrier
    Gründler, T.; Quednau, N.; Stump, C.; Orian-Rousseau, V.; Ishikawa, H.; Wolburg, H.; Schroten, H.; Tenenbaum, T.; Schwerk, C.
    2013. Microbes and Infection, 15, 291–01. doi:10.1016/j.micinf.2012.12.005 
  53. Aberrant mural cell recruitment to lymphatic vessels and impaired lymphatic drainage in a murine model of pulmonary fibrosis
    Meinecke, A. K.; Nagy, N.; D’Amico Lago, G.; Kirmse, S.; Klose, R.; Schrödter, K.; Zimmermann, A.; Helfrich, I.; Rundqvist, H.; Theegarten, D.; Anhenn, O.; Orian-Rousseau, V.; Johnson, R. S.; Alitalo, K.; Fischer, J. W.; Fandrey, J.; Stockmann, C.
    2012. Blood, 119, 5931–5942. doi:10.1182/blood-2011-12-396895 
  54. c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice
    Olaku, V.; Matzke, A.; Mitchell, C.; Hasenauer, S.; Sakkaravarthi, A.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2011. Molecular Biology of the Cell, 22, 2777–2786. doi:10.1091/mbc.E11-02-0134 
  55. CD44, a therapeutic target for metastasising tumours
    Orian-Rousseau, V.
    2010. European journal of cancer, 46 (7), 1271–77. doi:10.1016/j.ejca.2010.02.024 
  56. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis
    Tremmel, M.; Matzke, A.; Albrecht, I.; Laib, A. M.; Olaku, V.; Ballmer-Hofer, K.; Christofori, G.; Heroult, M.; Augustin, H. G.; Ponta, H.; Orian-Rousseau, V.
    2009. Blood, 114, 5236–44. doi:10.1182/blood-2009-04-219204 
  57. Involvement of CD44v6 in InIB-dependent Listeria invation
    Jung, C.; Matzke, A.; Niemann, H. H.; Schwerk, C.; Tenenbaum, T.; Orian-Rousseau, V.
    2009. Molecular Microbiology, 72, 1196–1207. doi:10.1111/j.1365-2958.2009.06716.x 
  58. CD44v6 peptides block metastasis and interfere with angiogenesis
    Matzke, A.; Tremmel, M.; Jannasch, K.; Albrecht, I.; Alves, F.; Ballmer-Hoffer, K.; Christofori, G.; Ponta, H.; Orian-Rousseau, V.
    2008. 3rd European Conf.on Tumor Angiogenesis and Antiangiogenic Therapy (ECTA 2008), Padova, I, November 6-8, 2008 
  59. Haploinsufficiency of c-Met in CD44-/- mice identifies a collaboration of CD44 and c-Met in vivo
    Matzke, A.; Sargsyan, V.; Holtmann, B.; Aramuni, G.; Asan, E.; Sendtner, M.; Pace, G.; Howells, N.; Zhang, W.; Ponta, H.; Orian-Rousseau, V.
    2007. Molecular and Cellular Biology, 27, 8797–8806. doi:10.1128/MCB.01355-07 
  60. The co-receptor function of CD44v6 for c-Met and for VEGFR2 in angiogenesis
    Tremmel, M.; Kastilan, T.; Pace, G.; Matzke, A.; Ponta, H.; Orian-Rousseau, V.
    2007. Vortr.: Paul Scherrer Institut, Villigen, CH, 20.März 2007 
  61. CD44v6 peptides block metastatic spreading
    Matzke, A.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2007. 4th IRCC Internat.Cancer Conf., Torino, I, June 7-9, 2007 Molecular Cancer Therapies : New Challenges and Horizons ; Beatson Internat.Cancer Conf., Glasgow, GB, June 17-20, 2007 
  62. Contribution of CD44v6 for c-Met activation and signaling: the co-receptor binds HGF and acts as an active organizer of a signalosome complex
    Matzke, A.; Kastilan, T.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2007. Gordon Research Conf.’Mechanisms of Cell Signalling’, Oxford, GB, September 16- 21, 2007 
  63. Cancer stem cell: Redefining cancer
    Orian-Rousseau, V.
    2007. Vortr.: Universität Karlsruhe, 2.Juli 2007 
  64. CD44v6 and c-Met co-operate in synaptogenesis and in metastasis formation
    Matzke, A.; Aramuni, G.; Sargsyan, V.; Zhang, W.; Holtmann, B.; Sendtner, M.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2007. 4th IRCC Internat.Cancer Conf., Torino, I, June 7-9, 2007 
  65. c-Met activation and signaling depends on CD44v6. The co-receptor organises a signalsome complex containing F-actin
    Orian-Rousseau, V.; Kastilan, T.; Pace, G.; Matzke, A.; Ponta, H.
    2007. BRECOSM Breast Cancer and Metastasis Conf., Paris, F, June 22-24, 2006 
  66. The role of CD44v6 as a co-receptor for c-Met
    Matzke, A.; Kastilan, T.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2007. FASEB Summer Research Conf., Tucson, Ariz., August 11-16, 2007 
  67. Ras activation by Sos requires F-actin bound to ERMs
    Orian-Rousseau, V.; Matzke, A.; Pace, G.; Kastilan, T.; Olaku, V.; Ponta, H.
    2007. Beatson Internat.Cancer Conf., Glasgow, GB, June 18-21, 2006 
  68. The Co-receptor function of CD44v6 for RTKs
    Orian-Rousseau, V.; Matzke, A.; Pace, G.; Kastilan, T.; Linfeng, C.; Ponta, H.
    2007. BRECOSM Breast Cancer and Metastasis Conf., Paris, F, June 22-24, 2006 
  69. CD44v6 acts as co-receptor for c-Met. Ras activation by Sos requires F-actin bound to ERMs
    Orian-Rousseau, V.; Matzke, A.; Pace, G.; Kastilan, T.; Okalu, V.; Ponta, H.
    2007. Growth Factors and Signalling : Gordon Research Conf., Connecticut College, New London, Conn., July 16-21, 2006 
  70. The coreceptor function of CD44v6 for c-Met accounts for metastasis
    Matzke, A.; Olaku, V.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2007. FASEB Summer Research Conf., Tucson, Ariz., August 11-16, 2007 Molecular Cancer Therapies : New Challenges and Horizons ; Beatson Internat.Cancer Conf., Glasgow, GB, June 17-20, 2007 
  71. The coreceptor function of CD44v6 in angiogenesis
    Tremmel, M.; Linfeng, C.; Matzke, A.; Orian-Rousseau, V.; Ponta, H.
    2007. 4th Internat.Kloster Seeon Meeting ’Angiogenesis’, Kloster Seeon, September 16- 19, 2006 
  72. New players in signal transduction: ERM proteins, F-actin and CD44
    Hasenauer, S.; Matzke, A.; Kastilan, T.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2007. Spring 2007 Meeting : A Joint Meeting of the Genetics Society and the British Societies for Cell and Developmental Biology, Edinburgh, GB, March 29 - April 1, 2007 
  73. CD44v6 peptides block metastatic spreading and interfere with angiogenesis
    Tremmel, M.; Matzke, A.; Ponta, H.; Orian-Rousseau, V.
    2007. The Tumor-Vessel Interface : Internat.Symp., Kloster Seeon, September 22-25, 2007 
  74. The coreceptor function of CD44v6 for c-Met accounts for metastasis
    Matzke, A.; Pace, G.; Ponta, H.; Orian-Rousseau, V.
    2007. Gordon Research Conf.’Mechanisms of Cell Signalling’, Oxford, GB, September 16-21, 2007 
  75. CD44 v6 - a co-receptor in angiogenesis
    Tremmel, M.; Matzke, A.; Albrecht, I.; Christofori, G.; Rothley, M.; Sleeman, J.; Ponta, H.; Orian-Rousseau, V.
    2007. 4th Internat.Kloster Seeon Meeting ’Angiogenesis’, Kloster Seeon, September 16-19, 2006 
  76. Von der Grundlagenforschung zur Entwicklung metastasenspezifischer Peptide
    Ponta, H.; Orian-Rousseau, V.
    2007. Nachrichten - Forschungszentrum Karlsruhe, 39, 123–27 Full textFull text of the publication as PDF document 
  77. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin
    Orian-Rousseau, V.; Morrison, H.; Matzke, A.; Kastilan, T.; Pace, G.; Herrlich, P.; Ponta, H.
    2007. Molecular Biology of the Cell, 18, 76–83. doi:10.1091/mbc.E06-08-0674 
  78. Molekulare Mechanismen in Tumormetastasierung: Kooperation von Adhäsionsproteinen und Rezeptortyrosinkinase. habilitation thesis
    Orian-Rousseau, V.
    2006. Universität Karlsruhe (TH) 
  79. A five-amino-acid peptide blocks Met and Ron dependent cell migration
    Matzke, A.; Herrlich, P.; Ponta, H.; Orian-Rousseau, V.
    2005. ELSO Meeting (European Life Scientist Organization), Dresden, September 3-6, 2005 
  80. A five-amino-acid peptide blocks Met- and Ron-dependent cell migration
    Matzke, A.; Herrlich, P.; Ponta, H.; Orian-Rousseau, V.
    2005. Cancer Research, 65, 6105–10 
  81. Genes upregulated in a metastasizing human colon carcinoma cell line
    Orian-Rousseau, V.; Mink, S.; Mengwasser, J.; HogenEsch, H.; Guo, F.; Thies, W. G.; Hofmann, M.; Herrlich, P.; Ponta, H.
    2005. International Journal of Cancer, 113, 699–705. doi:10.1002/ijc.20644 
  82. CD44v6 is a co-receptor for another member of the c-Met family, RON
    Matzke, A.; Herrlich, P.; Ponta, H.; Orian-Rousseau, V.
    2004. 2nd Internat.DFG Symp.’Cell Migration in Development and Disease’, Karlsruhe, October 10-13, 2004 
  83. The co-receptor function of CD44v6 towards c-Met in vitro and in vivo
    Orian-Rousseau, V. M.; Kastilan, T.; Herrlich, P. A.; Ponta, H.
    2004. 2nd Internat.DFG Symp.’Cell Migration in Development and Disease’, Karlsruhe, October 10-13, 2004 
  84. Aromatic amino acids at the surface of InlB are essential for host cell invasion by Listeria monocytogenes
    Machner, M. P.; Frese, S.; Schubert, W. D.; Orian-Rousseau, V.; Gherardi, E.; Wehland, J.; Niemann, H. H.; Heinz, D. W.
    2003. Molecular Microbiology, 48, 1525–1536 
  85. CD44, un regulateur de la croissance et de l’invasion cellulaire
    Orian-Rousseau, V.
    2003. M S - Medecine Sciences, 19, 405–407 
  86. CD44 is required for two consecutive steps in HGF/c-Met signalling
    Orian-Rousseau, V.; Chen, L.; Sleeman, J. P.; Herrlich, P.; Ponta, H.
    2002. Genes and Development, 16, 3074–86 
  87. Stop or go - CD44 als Regulator essentieller zellulärer Entscheidungen
    Ponta, H.; Orian-Rousseau, V.; Chen, L.; Morrison, H.; Herrlich, P.
    2002. Nachrichten - Forschungszentrum Karlsruhe, 34, 36–40 Full textFull text of the publication as PDF document 
  88. Two opposite functions of CE44 in cancer
    Orian-Rousseau, V.; Morrison, H.; Linfeng, C.; Ponta, H.; Herrlich, P.
    2001. 6th World Congress on Advances in Oncology, Creta Maris, GR, October 18-20, 2001 
  89. Two sides of one and the same molecule, CD44: tumor metastasis promotion and suppression
    Herrlich, P.; Morrison, H.; Linfeng, C.; Orian-Rousseau, V.; Ponta, H.
    2001. 2001 Annual Scientific Conf.of the General Motors Cancer Research Foundation (GMCRF), ’Mechanisms of Metastasis’, Bethesda, Md., June 5-6, 2001 
  90. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor
    Herrlich, P.; Morrison, H.; Sleeman, J.; Orian-Rousseau, V.; König, H.; Weg-Remers, S.; Ponta, H.
    2000. Colorectal Cancer: New Aspects of Molecular Biology and Immunology and Their Clinical Applications, Berlin, October 8-9, 2000 Annals of the New York Academy of Sciences, 910(2000) 
  91. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor
    Herrlich, P.; Morrison, H.; Sleeman, J.; Orian-Rousseau, V.; König, H.; Weg-Remers, S.; Ponta, H.
    2000. Annals of the New York Academy of Sciences, Colorectal Cancer: New Aspects of Molecular Biology and Immunology and Their Clinical Applications, Berlin, October 8-9, 2000, 910, 106–20